Sign up for the QMED & MD+DI Daily newsletter.
7 Products Boston Scientific is Betting on in 2014: Alair Bronchial Thermoplasty System7 Products Boston Scientific is Betting on in 2014: Alair Bronchial Thermoplasty System
Alair Bronchial Thermoplasty SystemThe first FDA-approved nondrug outpatient procedure to treat severe and persistent asthma, Alair saw 25% growth last year and is now offered at more than 350 worldwide treatment sites. Mahoney said reorder rates are improving and large commercial insurers are greenlighting it for more case-by-case approvals.
February 4, 2014
1 Min Read
.svg?width=1280&auto=webp&quality=95&format=jpg&disable=upscale "MDDI")
Alair Bronchial Thermoplasty System
The first FDA-approved nondrug outpatient procedure to treat severe and persistent asthma, Alair saw 25% growth last year and is now offered at more than 350 worldwide treatment sites. Mahoney said reorder rates are improving and large commercial insurers are greenlighting it for more case-by-case approvals.
[image courtesy of BOSTON SCIENTIFIC]
You May Also Like
.png?width=300&auto=webp&quality=80&disable=upscale)
_(2).png?width=300&auto=webp&quality=80&disable=upscale)